| |
COVID-19 LDCT
|
p value
|
|---|
|
Score
|
|---|
|
Mean ± SD
|
|---|
|
No
|
Yes
|
|---|
|
Clinical data
|
|
Sex (male/female)
|
5.1 ± 6.9
|
4.0 ± 6.0
|
0.247
|
|
Symptoms
|
4.3 ± 6.4
|
4.5 ± 6.5
|
0.834
|
|
Rhinitis
|
4.9 ± 6.7
|
3.9 ± 6.1
|
0.223
|
|
Fever
|
4.1 ± 6.4
|
6.9 ± 6.2
|
0.002
|
|
Anosmia
|
5.2 ± 7.3
|
3.7 ± 5.2
|
0.342
|
|
Ageusia
|
4.6 ± 6.8
|
4.4 ± 6.0
|
0.805
|
|
Dyspnea
|
3.5 ± 5.3
|
7.2 ± 8.3
|
< 0.001
|
|
Chest pain
|
4.6 ± 6.7
|
4.0 ± 5.1
|
0.89
|
|
Needed oxygen
|
4.0 ± 5.8
|
20.9 ± 7.9
|
< 0.001
|
|
Desaturation
|
3.5 ± 5.4
|
13.2 ± 7.8
|
< 0.001
|
|
Hospitalization
|
4.1 ± 6.0
|
15.3 ± 8.4
|
< 0.001
|
|
Hypertension
|
3.9 ± 5.9
|
10.0 ± 8.1
|
< 0.001
|
|
Diabetes
|
4.1 ± 6.2
|
12.0 ± 7.3
|
< 0.001
|
|
Cancer status
|
4.3 ± 6.3
|
11.3 ± 7.0
|
0.003
|
|
Cardiac disease
|
4.4 ± 6.4
|
9.1 ± 7.2
|
0.043
|
|
Demographics data
|
|
Age 18–34 years
|
1.4 ± 2.8
| |
< 0.001
|
|
Age 35–44 years
|
3.2 ± 5.0
| | |
|
Age 45–54 years
|
5.2 ± 5.6
| | |
|
Age 55–64 years
|
8.5 ± 9.1
| | |
|
Age > 64 years
|
10.0 ± 6.9
| | |
|
Delay between symptoms and LDCT
|
|
0–3 days
|
1.4 ± 3.6
| |
0.003
|
|
4–7 days
|
4.4 ± 6.8
| | |
|
8–11 days
|
4.7 ± 6.2
| | |
|
> 11 days
|
7.1 ± 7.3
| | |
- All significant results with a p < 0.05 have been highlighted in bold
- Distribution of the CT-SS according to symptoms across age and delay between symptoms and LDCT. The continuous variables are presented as the mean value ± DS
- COVID-19 coronavirus disease 2019, LDCT low-dose computed tomography, p value: Wilcoxon Mann–Whitney/Kruskal–Wallis test
